Premium
Loss and gain of chromosomes 1, 18, and Y in prostate cancer
Author(s) -
König Josée J.,
Teubel Wilma,
Van Dongen Jan Willem,
Romijn Johannes C.,
Hagemeijer Anne,
Schröder Fritz H.
Publication year - 1994
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.2990250602
Subject(s) - ploidy , biology , chromosome , aneuploidy , fluorescence in situ hybridization , karyotype , centromere , cytogenetics , dna , chromosome 7 (human) , microbiology and biotechnology , chromosome 17 (human) , genetics , gene
Nuclear suspensions of 42 prostate carcinoma specimens obtained at surgery were used to investigate loss and gain of chromosomes 1, 18, and Y by fluorescence in situ hybridization (FISH) with centromere‐specific probes. The outcome of FISH analysis was correlated with clinical parameters and the relationship between DNA‐FCM (ploidy at cellular level) and FISH (ploidy of individual chromosomes) was assessed. Significant loss of chromosomes 1 and 18 was infrequent (respectively, three and five cases), but 53% of the tested specimens showed loss of Y. Loss was not correlated with DNA ploidy. Significant gain occurred in 36% (chromosome 1), 63% (chromosome 18), and 28% (Y) of the specimens. Gain of chromosome 18 was shown in DNA diploid (7/14) and aneuploid tumors (18/26), while gain of chromosomes 1 and Y was nearly restricted to DNA aneuploid specimens. Significant unbalance between these chromosomes occurred in 11 cases. Most cases which had significant gain of chromosome 1 or 18 showed trisomic as well as tetrasomic cells. Simultaneous loss of some and gain of other investigated chromosomes is suggestive of clonal heterogeneity and/or multiclonality. This was observed in eight tumors. Correlation between DNA‐FCM and FISH was best for the Y chromosome. DNA‐FCM showed more aberrant histograms with increasing stage and grade of tumors. The presence of numerical aberrations of the investigated chromosomes however, seemed independent of clinical grade or stage. © 1994 Wiley‐Liss, Inc.